Full Event Guide

Download the Full Event Guide to Unlock:

30+

Industry-leading speakers from the likes of AstraZeneca, Novartis, EMD Serono, Artios Pharma, Repare Therapeutics, and more

6

Hours of intimate pre-conference networking and biomarker-focused discussions

8+

hours of dedicated networking time across speed networking, roundtable discussions, panels and more

1

Scientific poster session, giving you the opportunity to display your own research to this diverse  audience

Screenshot 2024-11-18 160550

Having trouble downloading the brochure? Let us know and we’ll email it to you instead

Exclusive Insights from the Likes Of:

Jatinder Mukker, Director, Quantitative Pharmacology, EMD Serono

Kirk Tanner, Chief Scientific Officer, National Brain Tumor Society

Hiroki Umehara, Senior Director, Sumitomo Pharma

David Proia, Vice President of Biology and Drug Discovery, Acrivon Therapeutics

Vera Grinkevich, Associate Director & Principal Scientist, Artios Pharma

Keith Mikule, Vice President, Business Development, InSilico Medicine

Companies on the 2025 Program:

logo-az
Merck & Co
Novartis
sumimoto pharma
Repare Therapeutics
Zentalis Pharmaceuticals
nerviano medical sciences
acrivon therapeutics
chordia therapeutics
eikon therapeutics
artios logo
blacksmith medicines
wayshine
FoRx Therapeutics
Boundless Bio
eisbach
allarity therapeutics
evariste
insilico medicine
national brain tumor society
Capture-logo-MD-Anderson-Cancer-Center
dana farber cancer institute
mayo clinic
tempus-logo-vector
1 - intoDNA logo